The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Marc C. Hochberg

Division of Rheumatology

University of Maryland School of Medicine

10 South Pine Street

MSTF 8-34

USA

[email]@umaryland.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Rheumatology, University of Maryland School of Medicine, 10 South Pine Street, MSTF 8-34, USA. 2000 - 2012
  • Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, USA. 2000 - 2010
  • University of Maryland School of Medicine, Baltimore, USA. 2001 - 2008

References

  1. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Hochberg, M.C., Altman, R.D., April, K.T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., Tugwell, P. Arthritis. Care. Res. (Hoboken) (2012) [Pubmed]
  2. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Hochberg, M.C. Osteoarthr. Cartil. (2010) [Pubmed]
  3. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate . Hochberg, M.C., Zhan, M., Langenberg, P. Curr. Med. Res. Opin (2008) [Pubmed]
  4. Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates. Hochberg, M.C. Curr. Osteoporos. Rep (2008) [Pubmed]
  5. Potential effects of chondroitin sulfate on joint swelling: a GAIT report. Hochberg, M.C., Clegg, D.O. Osteoarthr. Cartil. (2008) [Pubmed]
  6. Quality measures in osteoarthritis. Hochberg, M.C. Clin. Exp. Rheumatol. (2007) [Pubmed]
  7. Recommendations for measurement of bone mineral density and identifying persons to be treated for osteoporosis. Hochberg, M.C. Rheum. Dis. Clin. North Am. (2006) [Pubmed]
  8. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. Hochberg, M.C., Thompson, D.E., Black, D.M., Quandt, S.A., Cauley, J., Geusens, P., Ross, P.D., Baran, D. J. Bone Miner. Res. (2005) [Pubmed]
  9. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Hochberg, M.C., Lebwohl, M.G., Plevy, S.E., Hobbs, K.F., Yocum, D.E. Semin. Arthritis Rheum. (2005) [Pubmed]
  10. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Hochberg, M.C. Curr. Top. Med. Chem (2005) [Pubmed]
  11. Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. Hochberg, M.C., Lethbridge-Cejku, M., Tobin, J.D. Osteoarthr. Cartil. (2004) [Pubmed]
  12. COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients. Hochberg, M.C. Arthritis Res. Ther. (2003) [Pubmed]
  13. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Hochberg, M.C., Tracy, J.K., Hawkins-Holt, M., Flores, R.H. Ann. Rheum. Dis. (2003) [Pubmed]
  14. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. Hochberg, M.C., Greenspan, S., Wasnich, R.D., Miller, P., Thompson, D.E., Ross, P.D. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  15. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg, M.C. Clin. Exp. Rheumatol. (2001) [Pubmed]
  16. Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents. Hochberg, M. Drugs. Aging (2000) [Pubmed]
  17. Session 2: clinical aspects. Clinical assessment of hand OA. Hochberg, M.C., Vignon, E., Maheu, E. Osteoarthr. Cartil. (2000) [Pubmed]
 
WikiGenes - Universities